[Comorbidities after radical prostatectomy : Which subjective health restrictions are relevant for long-term survivors?]

IF 0.5 4区 医学 Q4 UROLOGY & NEPHROLOGY
Urologie Pub Date : 2025-01-01 Epub Date: 2024-09-20 DOI:10.1007/s00120-024-02441-0
Tobiasz Klorek, Anton N J H Schlichte, Cornelia Peter, Matthias Jahnen, Andreas Dinkel, Stefan Schiele, Lukas Lunger, Helga Schulwitz, Jürgen E Gschwend, Kathleen Herkommer
{"title":"[Comorbidities after radical prostatectomy : Which subjective health restrictions are relevant for long-term survivors?]","authors":"Tobiasz Klorek, Anton N J H Schlichte, Cornelia Peter, Matthias Jahnen, Andreas Dinkel, Stefan Schiele, Lukas Lunger, Helga Schulwitz, Jürgen E Gschwend, Kathleen Herkommer","doi":"10.1007/s00120-024-02441-0","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Radical prostatectomy (RP) is one of the most common therapeutic strategies for treating localized prostate cancer (PCa). Currently, the significance of postoperative functional limitations for affected patients in the long-term course, especially in comparison to age-related comorbidities, is unclear.</p><p><strong>Objective: </strong>The aim of this study was to quantify the prevalence of subjective health restrictions alongside functional deficits in long-term PCa survivors after RP and their relevance for subjective impairments in everyday life.</p><p><strong>Materials and methods: </strong>Using the German version of the Self-Administered Comorbidity Questionnaire (SCQ-D), 3173 long-term survivors after RP reported their comorbidities in 13 predefined categories and in 3 free-text fields along the dimensions \"problem,\" \"treatment,\" and \"impairment\".</p><p><strong>Results: </strong>The mean age at survey was 79.5 years (standard deviation, SD ± 6.4), with a mean time since RP of 17.4 years (SD ± 3.7). The three most frequently identified comorbidities/percentage of patients who felt impaired were: hypertension (62.2%/8.5%), back pain (44.1%/54.5%), and osteoarthritis (36.1%/54.1%). The most frequently mentioned additional health problems can be subsumed under the umbrella term \"urological problems\" (6.1%/72.7%): incontinence (4.8%/74.3%), bladder problems (1.1%/61.8%), and erectile dysfunction (0.5%/47.1%).</p><p><strong>Conclusion: </strong>In summary, non-cancer-related comorbidities in the long-term course after RP are often perceived as \"problems\" but rarely lead to subjective impairment. In contrast, treatment-related urological problems are rarely reported as \"problems\", but they very often lead to subjective impairment in everyday life.</p>","PeriodicalId":29782,"journal":{"name":"Urologie","volume":" ","pages":"29-37"},"PeriodicalIF":0.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732866/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Urologie","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s00120-024-02441-0","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/20 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Radical prostatectomy (RP) is one of the most common therapeutic strategies for treating localized prostate cancer (PCa). Currently, the significance of postoperative functional limitations for affected patients in the long-term course, especially in comparison to age-related comorbidities, is unclear.

Objective: The aim of this study was to quantify the prevalence of subjective health restrictions alongside functional deficits in long-term PCa survivors after RP and their relevance for subjective impairments in everyday life.

Materials and methods: Using the German version of the Self-Administered Comorbidity Questionnaire (SCQ-D), 3173 long-term survivors after RP reported their comorbidities in 13 predefined categories and in 3 free-text fields along the dimensions "problem," "treatment," and "impairment".

Results: The mean age at survey was 79.5 years (standard deviation, SD ± 6.4), with a mean time since RP of 17.4 years (SD ± 3.7). The three most frequently identified comorbidities/percentage of patients who felt impaired were: hypertension (62.2%/8.5%), back pain (44.1%/54.5%), and osteoarthritis (36.1%/54.1%). The most frequently mentioned additional health problems can be subsumed under the umbrella term "urological problems" (6.1%/72.7%): incontinence (4.8%/74.3%), bladder problems (1.1%/61.8%), and erectile dysfunction (0.5%/47.1%).

Conclusion: In summary, non-cancer-related comorbidities in the long-term course after RP are often perceived as "problems" but rarely lead to subjective impairment. In contrast, treatment-related urological problems are rarely reported as "problems", but they very often lead to subjective impairment in everyday life.

[前列腺癌根治术后的并发症:哪些主观健康限制与长期幸存者相关?]
背景:根治性前列腺切除术(RP)是治疗局部前列腺癌(PCa)最常见的治疗策略之一。目前,受影响患者术后长期功能受限的意义尚不明确,尤其是与年龄相关的合并症相比:本研究旨在量化 PCa 术后长期存活者的主观健康限制与功能障碍的发生率,以及它们与日常生活中主观障碍的相关性:使用德文版自编合并症问卷(SCQ-D),3173名RP术后长期存活者按照 "问题"、"治疗 "和 "损伤 "三个维度,在13个预定义类别和3个自由文本字段中报告了他们的合并症:调查时的平均年龄为 79.5 岁(标准差,SD ± 6.4),RP 后的平均时间为 17.4 年(SD ± 3.7)。最常见的三种合并症/感觉受损的患者比例分别为:高血压(62.2%/8.5%)、背痛(44.1%/54.5%)和骨关节炎(36.1%/54.1%)。最常提及的其他健康问题可归纳为 "泌尿系统问题"(6.1%/72.7%):尿失禁(4.8%/74.3%)、膀胱问题(1.1%/61.8%)和勃起功能障碍(0.5%/47.1%):总之,在 RP 术后的长期病程中,与癌症无关的合并症通常被视为 "问题",但很少导致主观功能障碍。与此相反,与治疗相关的泌尿系统问题很少被报告为 "问题",但却经常导致日常生活中的主观障碍。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Urologie
Urologie UROLOGY & NEPHROLOGY-
CiteScore
1.00
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信